Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotherapy and urological malignancy].

K Marumo1

  • 1Department of Urology, School of Medicine, Keio University.

Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basic research and clinical application of beta-tricalcium phosphate (β-TCP).

Morphologie : bulletin de l'Association des anatomistes·2017
Same author

DS02R1: Improvements to Atomic Bomb Survivors' Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses.

Health physics·2016
Same author

Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

An Injectable Complex of β-tricalcium Phosphate Granules, Hyaluronate, and rhFGF-2 on Repair of Long-bone Fractures with Large Fragments.

The open biomedical engineering journal·2014
Same author

Serum oestradiol levels in male partners of infertile couples.

Andrologia·2014
Same author

The dipeptidyl peptidase-4 inhibitor vildagliptin has the capacity to repair β-cell dysfunction and insulin resistance.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
Same journal

[CASE OF EPIDIDYMITIS LEADING TO DIAGNOSIS OF INCOMPLETE BEHCET'S DISEASE].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
Same journal

[A CASE OF INGUINAL HERNIA MESH MIGRATION INTO THE BLADDER].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
Same journal

[A CASE OF PENILE VERRUCOUS CARCINOMA: DIAGNOSTIC DIFFICULTIES WITH BIOPSY].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
Same journal

[MUSCLES MAY MOVE NOT ONLY TO THE LONGITUDINAL DIRECTION BUT ALSO TO THE LATERAL DIRECTION ----- A NEW PRINCIPLE DEVELOPED FROM THE OPENING ACTIVITY OF THE URETHRA ----].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
Same journal

[A CASE OF ACUTE EXACERBATION OF INTERSTITIAL PNEUMONIA AFTER ROBOT-ASSISTED TOTAL CYSTECTOMY].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
Same journal

[ENTERIC ADENOCARCINOMA DIAGNOSED VIA IMMUNOHISTOCHEMISTRY AND GENOME TESTING OF A PORT SITE MASS AFTER ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: A CASE REPORT].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2026
See all related articles

Immunotherapy has shown promise for urological cancers since the 1960s. Combining agents may improve treatment outcomes for advanced renal cell carcinoma and bladder cancer.

Area of Science:

  • Oncology
  • Immunology

Context:

  • Immunotherapy emerged as a cancer treatment in the 1960s.
  • Trials explored tumor vaccines, immunopotentiators, interferons, and cytokines for urological malignancies.
  • Current immunotherapy is vital for advanced renal cell carcinoma and superficial bladder carcinoma.

Purpose:

  • To review the role and progress of immunotherapy in urological malignancies.
  • To highlight the limitations of single-agent therapies like interferon and interleukin-2.
  • To advocate for combination strategies in treating urological cancers.

Summary:

  • Early immunotherapy trials demonstrated antitumor effects in urological cancers.
  • While effective for certain conditions, single agents like interferon and interleukin-2 did not meet initial expectations.

Related Experiment Videos

  • Developing combination therapies based on research is crucial for advancing treatment.

    • Impact:

    • Immunotherapy is a cornerstone in treating advanced renal cell carcinoma and superficial bladder carcinoma.
    • The study emphasizes the need for rational, multi-agent immunotherapy strategies.
    • Future progress in urological cancer treatment hinges on innovative combination approaches.